Jacqueline Scanlan is VP at HAEMONETICS CORP (HAE). They have made 24 open-market trades across 3 companies since 2018, most recently 2026-09-28.
CIK 0001713517
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 24 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FMC | SELL · 10b5-1 | 2025-09-29 | 2025-09-30 | $34.00 | $129K | -12.8% | -53.4% | -58.5% |
| FMC | SELL | 2025-08-18 | 2025-08-19 | $37.49 | $113K | +1.3% | -3.6% | -66.5% |
| FMC | SELL | 2024-11-11 | 2024-11-13 | $59.67 | $540K | +9.0% | -3.8% | -34.5% |
| AXTA | SELL | 2023-08-09 | 2023-08-11 | $29.48 | $1.0M | -0.1% | -4.1% | +4.4% |
| HAE | SELL | 2021-06-07 | 2021-06-09 | $55.09 | $11K | +8.8% | +8.9% | +10.7% |
| HAE | SELL | 2021-05-19 | 2021-05-21 | $55.19 | $6K | -2.1% | +12.3% | +2.2% |
| HAE | SELL | 2021-05-17 | 2021-05-18 | $55.97 | $6K | +1.7% | +12.7% | +5.9% |
| HAE | SELL | 2021-03-08 | 2021-03-10 | $120.07 | $13K | -3.2% | -2.1% | -51.9% |
| HAE | SELL | 2020-06-12 | 2020-06-16 | $90.03 | $2.4M | -3.8% | +1.6% | -1.7% |
| HAE | SELL | 2020-06-08 | 2020-06-10 | $97.03 | $31K | -9.5% | -6.1% | -2.8% |
| HAE | SELL | 2020-05-15 | 2020-05-19 | $100.44 | $11K | +5.8% | -17.4% | -17.7% |
| HAE | SELL | 2020-03-06 | 2020-03-10 | $100.34 | $293K | -20.0% | -1.4% | -5.3% |
| HAE | SELL | 2019-10-09 | 2019-10-10 | $124.12 | $324K | -3.0% | -6.7% | -10.0% |
| HAE | SELL | 2019-10-08 | 2019-10-10 | $122.34 | $281K | -3.0% | -6.7% | -10.0% |
| HAE | SELL | 2019-10-08 | 2019-10-10 | $123.23 | $641K | -3.0% | -6.7% | -10.0% |
| HAE | SELL | 2019-09-09 | 2019-09-11 | $127.44 | $390K | +3.4% | +3.6% | -5.2% |
| HAE | SELL | 2019-06-17 | 2019-06-18 | $112.49 | $791K | +5.0% | +7.2% | +9.9% |
| HAE | SELL | 2019-06-12 | 2019-06-13 | $109.37 | $12K | +4.5% | +10.6% | +10.5% |
| HAE | SELL | 2019-06-07 | 2019-06-10 | $103.38 | $22K | +8.7% | +11.8% | +11.8% |
| HAE | SELL | 2019-05-14 | 2019-05-16 | $100.00 | $151K | -3.0% | +12.2% | +33.5% |
| HAE | SELL | 2019-03-07 | 2019-03-11 | $83.57 | $10K | +0.9% | +1.6% | +23.0% |
| HAE | SELL | 2018-12-12 | 2018-12-14 | $104.22 | $214K | -6.9% | -4.2% | -14.8% |
| HAE | SELL | 2018-09-10 | 2018-09-12 | $112.19 | $1.1M | +1.1% | -4.5% | -7.4% |
| HAE | SELL | 2018-06-07 | 2018-06-08 | $92.73 | $20K | -2.4% | -1.4% | +18.1% |
| HAE | SELL | 2018-03-06 | 2018-03-08 | $72.23 | $8K | -0.0% | -2.2% | +30.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.